Georg Rüedi

About

Biotech entrepreneur committed to transforming cutting-edge science and technology into impactful therapies that address unmet medical needs. With deep experience in discovery and preclinical development, I combine scientific insight with operational leadership to build high-performing organizations.

Experience

• CEO & Co-Founder at Nanolynx Biologics
  Jun 2025 - Present · 1 yr 2 mos

  Nanolynx is developing conditionally active nanobody-drug conjugates for hard-to-treat solid tumors.

• Board Member at Stiftung FHNW
  Apr 2024 - Present · 2 yrs 4 mos

• CSO at molab.ai
  Feb 2025 - Jul 2025 · 6 mos

• Idorsia Pharmaceuticals Ltd (7 yrs 8 mos)
  • Senior Director, Head of Chemistry Technologies and Process R&D
    Oct 2023 - Jan 2025 · 1 yr 4 mos

    Managing director of a synthesis and technology department with operational and strategic leadership responsibilities including: - Digitalization, robotics and lab automation - Library synthesis, enabling and green chemistries - IND-enabling API batch production and tech transfer to CDMOs - Analytics, purification & method development - External alliances with CROs, pharma/biotech and academic institutions - Financial planning and analysis

  • Senior Director, Head of Chemistry Technologies and Lead Discovery
    Jun 2017 - Sep 2023 · 6 yrs 4 mos

    Managing director of a science and technology group with operational and strategic leadership responsibilities including: - Hit finding (drug modalities, corporate library and screening technologies) - Lead discovery (hit-to-lead chemistry, early discovery pipeline) - Computer-aided drug design (CADD) - AI/ML-driven drug design and discovery strategy - Scientific computing - Analytics, purification & method development - Scientific project evaluation across therapeutic areas

• Actelion (11 yrs 8 mos)
  • Director, Head of Anti-infectives Chemistry
    Jan 2013 - May 2017 · 4 yrs 5 mos

    Research group leader (20+ people) in antibiotic drug discovery with operational and strategic responsibilities including: - Portfolio Management - Competitive intelligence and due diligence - Intellectual property and patent strategy - Scientific project evaluation across therapeutic areas - Public private partnerships and fundraising - Outsourcing, budgeting and resource allocation

  • Research Scientist, Medicinal Chemistry
    Oct 2005 - Dec 2012 · 7 yrs 3 mos

    Lab head in hit-to-lead and lead optimization projects (up to three technicians/associates/trainees) - Project leadership experience in cross-functional matrix organizations - Key expertise in total synthesis and scale up of complex antibiotics - Prodrug strategy and formulation development - Intellectual property and patent writing